43.6486362, -79.3817439

366 Bay Street,
Suite 301,
Toronto, ON, M5H 4B2, Canada

SOL Investments Corp - Ordinary Shares

About Us

Scythian Biosciences Corp is a pre-clinical research and development company. It is engaged in the process of development of cannabinoid-based combination drug therapies for the treatment of concussions and traumatic brain injury.

SOL Global Investments Corp. operates as a cannabis company in the United States. The company was formerly known as Scythian Biosciences Corp. and changed its name to SOL Global Investments Corp. in October 2018.

SCCYF
SOL Investments Corp - Ordinary Shares
0.000
USD
0
(0%)